本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Denali Therapeutics Inc.

15.50
+0.07000.45%
盤後15.500.00000.00%16:19 EDT
成交量:217.58萬
成交額:3,348.15萬
市值:22.66億
市盈率:-5.52
高:15.69
開:15.45
低:15.06
收:15.43
52周最高:33.33
52周最低:10.57
股本:1.46億
流通股本:1.32億
量比:0.70
換手率:1.65%
股息:- -
股息率:- -
每股收益(TTM):-2.8082
每股收益(LYR):-2.5705
淨資產收益率:-39.69%
總資產收益率:-24.99%
市淨率:2.21
市盈率(LYR):-6.03

資料載入中...

2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/16

重要事件披露

Form 8-K - Current report
2024/02/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/30

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities